When to treat prostate cancer patients based on their PSA dynamics

References

• Agresti , A. 1996 . An Introduction to Categorical Data Analysis , New York : John Wiley & Sons, Inc .
   Google Scholar
• Alagoz , O. , Maillart , L. M. , Schaefer , A. J. and Roberts , M. S. 2007 . Determining the acceptance of cadaveric livers using an implicit model of the waiting list . Operations Research , 55 ( 1 ) : 24 – 36 .
   Web of Science ®Google Scholar
• American Cancer Society . 2008 . Detailed Guide: Prostate Cancer. , Atlanta , GA : American Cancer Society . [online]. Available at: www.cancer.org/docroot/CRI/CRI_2_3x.asp?dt = 36
   Google Scholar
• BC Cancer Agency . 2009 . Prostate Cancer: BC Cancer Agency , Vancouver , BC : BC Cancer Agency . [online]. Available at: www.bccancer.bc.ca
   Google Scholar
• Celeux , G. and Soromenho , G. 1996 . An entropy criterion for assessing the number of clusters in a mixture model . Journal of Classification , 13 : 195 – 212 .
   Web of Science ®Google Scholar
• D’Amato , R. , D’Aquila , R. and Wein , L. 2000 . Management of antiretroviral therapy for HIV infection: analyzing when to change therapy . Management Science , 50 ( 10 ) : 1200 – 1213 .
   Google Scholar
• Denham , J. , Steigler , A. , Wilcox , C. , Lamb , D. , Joseph , D. , Atkinson , C. , Matthews , J. , Tai , K-H. , Spry , N. , Christie , D. , Gleeson , P. S. , Greer , P. and D’Este , C. 2008 . Time to biochemical failure and prostate-specific antigen doubling time as surrogates for prostate cancer-specific mortality: evidence from the TROG 96.01 randomized controlled trial . The Lancet Oncology , 9 ( 11 ) : 1058 – 1068 .
   Web of Science ®Google Scholar
• Fieller , E. C. 1932 . The distribution of the index in a normal bivariate population . Biometrika , 24 : 428 – 440 .
   Google Scholar
• Fraley , C. and Raftery , A. E. 1998 . How Many Clusters? Which Clustering Method? Answers via Model-Based Cluster Analysis . The Computer Journal , 41 ( 8 ) : 578 – 588 .
   Web of Science ®Google Scholar
• Fraley , C. and Raftery , A. E. 2002 . Model-based clustering, discriminant analysis, and density estimation . Journal of the American Statistical Association , 97 : 611 – 631 .
   Web of Science ®Google Scholar
• Fraley , C. and Raftery , A. E. 2006 . MCLUST version 3 for R: Normal mixture modeling and model-based clustering , University of Washington, Department of Statistics, Seattle, WA . Technical Report 504
   Google Scholar
• Gleave , M. E. , La Bianca , S. and Goldenberg , S. L. 2000 . Neodajuvant hormonal therapy prior to radical prostatectomy: promises and pitfalls . Prostate Cancer and Prostatic Diseases , 3 : 136 – 144 .
   Web of Science ®Google Scholar
• Goldie , J. H. and Coldman , A. J. 1979 . A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate . Cancer Treatment Reports , 63 ( 11–12 ) : 1727 – 1733 .
   PubMedGoogle Scholar
• Harvey , A. 1991 . Forecasting Structural Time Series Models and the Kalman Filter. , 100 – 167 . Cambridge , , UK : Cambridge University Press .
   Google Scholar
• Heymann , J. J. , Benson , M. C. , O’Toole , K. M. , Malyszko , B. , Brody , R. , Vecchio , D. , Schiff , P. B. , Mansukhani , M. M. and Ennis , R. D. 2007 . Phase II study of neoadjuvant androgen deprivation followed by external-beam radiotherapy with 9 months of androgen deprivation for intermediate- to high-risk localized prostate cancer . Journal of Clinical Oncology , 25 ( 1 ) : 77 – 84 .
   Web of Science ®Google Scholar
• Hinkley , D. V. 1969 . On the ratio of two correlated normal random variables . Biometrika , 56 ( 3 ) : 635 – 639 .
   Web of Science ®Google Scholar
• Horwitz , E. M. and Hanks , G. E. 2000 . “ Hormonal therapy combined with radiation or surgery in treatment of locally advanced non-metastatic prostate cancer ” . In Comprehensive Textbook of Genitourinary Oncology , Edited by: Vogelzang , N. J. , Scardino , P. T. , Shipley , W. U. , Coffey , D. S. and Miles , B. J. 782 – 789 . Philadelphia , PA : Lippincott Williams & Wilkins .
   Google Scholar
• Inoue , L. I. T. , Etzioni , R. , Morrell , C. and Müller , P. 2008 . Modeling disease progression with longitudinal marker . Journal of the American Statistical Association , 103 ( 481 ) : 259 – 270 .
   PubMed Web of Science ®Google Scholar
• Knobbe , E. J. and Buckingham , B. 2005 . The extended Kalman Filter for continuous glucose monitoring . Diabetes Technology & Therapeutics , 7 ( 1 ) : 15 – 27 .
   Google Scholar
• Kristiansen , N. K. , Sjöström , S.-O. and Nygaard , H. 2005 . Urinary bladder volume tracking using a Kalman Filter . Medical and Biological Engineering and Computing , 43 ( 3 ) : 331 – 334 .
   Web of Science ®Google Scholar
• Kurt , M. , Denton , B. T. , Schaefer , A. J. , Shah , N. D. and Smith , S. A. 2011 . The structure of optimal statin initiation policies for patients with type 2 diabetes . IIE Transactions on Healthcare Systems Engineering , 1 : 49 – 65 .
   Google Scholar
• Lavieri , M. S. 2009 . Nursing workforce planning and radiation therapy treatment decision making: two healthcare operations research applications , Ph.D thesis. University of British Columbia, Vancouver, BC, Canada .
   Google Scholar
• Lavieri , M. S. , Puterman , M. L. and Tyldesley , S. 2012 . Modeling of PSA dynamics of prostate cancer patients receiving neoadjuvant hormone therapy prior to radiation therapy . Working manuscript
   Google Scholar
• Law , N. J. , Taylor , J. and Sandler , H. 2002 . The joint modeling of a longitudinal disease progression marker and the failure time process in the presence of cure . Biostatistics , 3 ( 4 ) : 547 – 563 .
   PubMed Web of Science ®Google Scholar
• Lin , H. , Turnbull , B. W. , McCulloch , C. E. and Slate , E. H. 2002 . Latent class models for joint analysis of longitudinal biomarker and event process data . Journal of the American Statistical Association , 97 ( 457 ) : 53 – 65 .
   Web of Science ®Google Scholar
• Makarov , D. V. , Trock , B. J. , Humphreys , E. B. , Mangold , L. A. , Walsh , P. C. , Epstein , J. I. and Partin , A. W. 2007 . Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005 . Urology , 69 ( 6 ) : 1095 – 1101 .
   PubMed Web of Science ®Google Scholar
• Morrell , C. H. , Sheng , S. L. and Brant , L. J. 2011 . A comparative study of approaches for predicting prostate cancer from longitudinal data in communications . Statistics-Simulation and Computation , 40 ( 9 ) : 1494 – 1513 .
   Web of Science ®Google Scholar
• Morris , W. J. 2009 . Androgen Suppression Combined With Elective Nodal and Dose Escalated Radiation Therapy . NCI Clinical Trials Inventory , National Cancer Institute [online]. Available at: www.cancer.gov/search/ViewClinicalTrials.aspx?cdrid=453036&version = HealthProfessional&protocolsearchid = 6093623 (accessed November 2009)
   Google Scholar
• National Cancer Institute . 2011 . Cancer Statistics Home Page – National Cancer Institute Available at: www.cancer.gov/statistics/ (accessed March 2012)
   Google Scholar
• Niblock , P. , Pickles , T. and the British Columbia Cancer Agency Prostate Cohort Outcomes Initiative . 2006 . Rising prostate-specific antigen values during neoadjuvant androgen deprivation therapy: the importance of monitoring . International Journal of Radiation Oncology Biology Physics , 65 ( 1 ) : 59 – 64 .
   Web of Science ®Google Scholar
• Oehlert , G. W. 1992 . A note on the Delta Method . American Statistician , 46 ( 1 ) : 27 – 29 .
   Web of Science ®Google Scholar
• Parker , R. S. , Doyle , F. J. III and Peppas , N. A. 1999 . A model-based algorithm for blood glucose control in type i diabetic patients . Biomedical Engineering, IEEE Transactions , 46 ( 2 ) : 148 – 157 .
   Web of Science ®Google Scholar
• Partin , A. W. and Carter , B. 2000 . “ Use of prostate-specific antigen density and velocity ” . In Comprehensive Textbook of Genitourinary Oncology , Edited by: Vogelzang , N. J. , Scardino , P. T. , Shipley , W. U. , Coffey , D. S. and Miles , B. J. 650 – 654 . Philadelphia , PA : Lippincott Williams & Wilkins .
   Google Scholar
• Rehbinder , H. , Forsgren , C. and Löf , J. 2004 . Adaptive radiation therapy for compensation of errors in patient setup and treatment delivery . Medical Physics , 31 ( 12 ) : 3363 – 3371 .
   Web of Science ®Google Scholar
• Sandblom , G. , Holmberg , L. , Damber , J. E. , Hugosson , J. , Johansson , J. E. , Lundgren , R. , Mattsson , E. , Nilsson , J. and Varenhorst , E. 2002 . Prostate-specific antigen as surrogate for characterizing prostate cancer subgroups . Scandinavian Journal of Urology & Nephrology , 36 ( 2 ) : 106 – 112 .
   PubMed Web of Science ®Google Scholar
• Shechter , S. M. , Bailey , M. D. , Schaefer , A. J. and Roberts , M. S. 2008 . The optimal time to initiate HIV therapy under ordered health states . Operations Research , 56 ( 1 ) : 20 – 33 .
   Web of Science ®Google Scholar
• Yu , M. , Taylor , J. M. G. and Sandler , H. M. 2008 . Individual prediction in prostate cancer studies using a joint longitudinal survival–cure model . Journal of the American Statistical Association , 103 ( 481 ) : 178 – 187 .
   Web of Science ®Google Scholar
• Zhu , H. and Rohwer , R. 1996 . Bayesian regression filters and the issue of priors . Neural Computing & Applications , 4 ( 3 ) : 130 – 142 .
   Web of Science ®Google Scholar